NeuroMetrix, Inc.
NURO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $6 | $8 | $8 |
| % Growth | -48.6% | -28.5% | 0% | – |
| Cost of Goods Sold | $1 | $2 | $3 | $2 |
| Gross Profit | $2 | $4 | $6 | $6 |
| % Margin | 55.4% | 66.9% | 69.6% | 71.7% |
| R&D Expenses | $2 | $3 | $3 | $3 |
| G&A Expenses | $6 | $5 | $4 | $4 |
| SG&A Expenses | $9 | $8 | $7 | $6 |
| Sales & Mktg Exp. | $2 | $3 | $3 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10 | $11 | $10 | $8 |
| Operating Income | -$9 | -$7 | -$5 | -$2 |
| % Margin | -289.6% | -121.2% | -57.4% | -27.7% |
| Other Income/Exp. Net | $1 | $1 | $0 | $0 |
| Pre-Tax Income | -$8 | -$7 | -$4 | -$2 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$8 | -$7 | -$4 | -$2 |
| % Margin | -257.4% | -110.6% | -52.9% | -26.7% |
| EPS | -3.96 | -6.27 | -4.9 | -0.86 |
| % Growth | 36.8% | -28% | -469.8% | – |
| EPS Diluted | -3.96 | -6.27 | -4.9 | -0.86 |
| Weighted Avg Shares Out | 2 | 1 | 1 | 3 |
| Weighted Avg Shares Out Dil | 2 | 1 | 1 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$9 | -$7 | -$5 | -$2 |
| % Margin | -289.6% | -120.2% | -56.8% | -26.8% |